Collection of Blood From Patients With Cancer
Recruiting
1,750 enrolled
Single-cell Multiomics and Spatiotemporal Omics Analyze the Mechanism of Liver Degenerative Disease
Recruiting
240 enrolled
A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy
Phase 1/2 Recruiting
126 enrolled
Electrochemotherapy (ECT) in Patients With Primary Visceral Tumors and/or Secondary Visceral Localizations, of Any Histotype
Phase NA Recruiting
24 enrolled
Symbiotic-GI-13: A Study to Learn About Study Medicine Called PF-08634404 as a Single Treatment and Combination Treatment in Adult Participants With a Liver Cancer Called Hepatocellular Carcinoma, That is Too Advanced to be Removed by Surgery and May Have Spread to Other Parts of the Body.
Phase 1/2 Recruiting
138 enrolled
Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors
Phase 1 Recruiting
40 enrolled
Follow-Up Study of Subjects Previously Enrolled in Poxviral Vector Gene Transfer Studies
Recruiting
750 enrolled
GPC3 Targeted CAR-T Cell Therapy in Advanced GPC3 Expressing Solid Tumor Malignancies
Phase 1 Recruiting
38 enrolled
Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor Expressed in T Cells for Pediatric Solid Tumors
Phase 1 Recruiting
24 enrolled
Kirros
Phase 2 Recruiting
30 enrolled
ELUCIDATE
Recruiting
400 enrolled
Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study)
Recruiting
5,000 enrolled
A Study to Evaluate ALN-BCAT in Patients With Hepatocellular Carcinoma
Phase 1 Recruiting
158 enrolled
DP-04
Recruiting
100 enrolled
Large Language Models Assist in Tumor MDT
Phase NA Recruiting
60 enrolled
RADIANT
Phase 2 Recruiting
15 enrolled
INDIGO
Phase NA Recruiting
51 enrolled
DUET-HCC
Phase 1/2 Recruiting
30 enrolled
Optimizing Y90 Therapy for Radiation Lobectomy
Recruiting
104 enrolled
A Study to Evaluate the Tolerability, Safety, and PK of AST-201 in Patients With GPC3-positive Advanced Solid Tumors
Phase 1 Recruiting
70 enrolled
(CLOCS-2)
Recruiting
2,900 enrolled
A Study to Assess Adverse Events and Change in Disease Activity of Intravenously (IV) Infused ABBV-324 in Adult Participants With Hepatocellular Cancer (HCC) or Squamous-Cell Non-Small Cell Lung Cancer (LUSC)
Phase 1 Recruiting
232 enrolled
QUS in HCC
Recruiting
328 enrolled
Histotripsy Plus Chemotherapy vs Chemotherapy Alone for Advanced Colorectal Liver Metastasis
Phase NA Recruiting
100 enrolled
IBPM
Recruiting
315 enrolled
Feasibility Study of CBCT for IGRT in Cancer Patients
Phase NA Recruiting
50 enrolled
FASTRAK
Phase NA Recruiting
944 enrolled
MR Guidance for Liver and Pancreas
Recruiting
30 enrolled
MOMENTUM
Recruiting
8,000 enrolled
Development and Testing of a Patient-facing Educational Tool About Liver Cancer Prevention
Recruiting
40 enrolled
Safety and Efficacy of Transarterial ICG Fluorescence-Guided Laparoscopic Anatomical Liver Resection
Recruiting
200 enrolled
Transdiscal vs Paravertebral Neurolytic Splanchnic Nerve Block for Upper Abdominal Cancer Pain
Phase NA Recruiting
56 enrolled
I-GROWtoh
Recruiting
2,000 enrolled
Riluzole For Preventing Cognitive Dysfunction in Ca Pts Receiving Chemo (REFOCUS): Pilot Trial
Phase 2 Recruiting
24 enrolled
MICRO-VAR
Recruiting
90 enrolled
Checkpoint Inhibition In Pediatric Hepatocellular Carcinoma
Phase 2 Recruiting
18 enrolled
Virtual Reality for GI Cancer Pain to Improve Patient Reported Outcomes
Phase NA Recruiting
360 enrolled
A First in Human Study of PLT012 in Participants With Solid Tumor Cancers
Phase 1 Recruiting
36 enrolled
SELECT-CAR-NK
Phase 1/2 Recruiting
85 enrolled
EBNK-ST-001
Phase 1/2 Recruiting
83 enrolled
Biobank for Cholestatic Liver Diseases.
Recruiting
9,150 enrolled
Contrast Enhanced Ultrasound to Evaluate Response to Chemoembolization in Patients With Liver Tumors
Phase 2 Recruiting
266 enrolled
IMPACT
Phase 1 Recruiting
21 enrolled
LivMOD
Recruiting
800 enrolled
A Study to Evaluate Safety, Tolerability and Preliminary Activity of AGX101 in Participants With Advanced Solid Tumors
Phase 1 Recruiting
80 enrolled
The Sarah Nanotechnology System for Treatment of Advanced Metastatic Solid Tumors Using Hyperthermia.
Phase NA Recruiting
9 enrolled
REGULUS: MRI-guided Adaptive SABR for Liver Cancers
Phase 2 Recruiting
62 enrolled
SAFER-L
Phase NA Recruiting
128 enrolled
BLOOD-TACE-P
Recruiting
15 enrolled
A Study of SH009 Injection in Patients With Advanced Solid Tumors.
Phase 1 Recruiting
150 enrolled